CE vs IRWD · rev $5.09B vs P/E 5.7, rev $219.5M
Celanese Corporation (CE) versus Ironwood Pharmaceuticals Inc (IRWD) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
Ironwood Pharmaceuticals Inc (IRWD) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported CE revenue for 2026-06-30 was $5.09B. Net income was $169.0M. CE currently screens at market cap $5.92B.
Latest reported IRWD revenue for 2026-06-30 was $219.5M. Net income was $92.1M. IRWD currently screens at market cap $579.4M and trailing P/E 5.7.
CE currently screens at market cap $5.92B. IRWD currently screens at market cap $579.4M and trailing P/E 5.7.
Not investment advice. Open the CE and IRWD stock pages for the full models.
Not investment advice.